| Hans-Günter Meyer-Thompson | Amphetamine
Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial.
Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial.
Marseille E, Mitchell JM, Kahn JG (2022)
PLoS ONE 17(2): e0263252. doi.org/10.1371/journal.pone.0263252
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0263252